Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Gilead Sciences Inc.

    NASDAQ: GILD · Real-Time Price · USD
    110.72
    0.74 (0.67%)
    At close: Jun 16, 2025, 3:59 PM
    110.20
    -0.47%
    After-hours: Jun 16, 2025, 07:09 PM EDT

    Gilead Sciences Statistics

    Share Statistics

    Gilead Sciences has 1.24B shares outstanding. The number of shares has increased by -0.04% in one year.

    Shares Outstanding

    n/a
    		 1.24B

    Shares Change (YoY)

    n/a
    		 -0.04%

    Shares Change (QoQ)

    n/a
    		 -0.07%

    Owned by Institutions (%)

    n/a
    		 85.05%

    Shares Floating

    n/a
    		 1.24B

    Failed to Deliver (FTD) Shares

    n/a
    		 9,506

    FTD / Avg. Volume

    n/a
    		 0.1%

    Short Selling Information

    The latest short interest is 20.94M, so 1.68% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.94M

    Short % of Shares Out

    n/a
    		 1.68%

    Short % of Float

    n/a
    		 1.68%

    Short Ratio (days to cover)

    n/a
    		 2.75

    Valuation Ratios

    The PE ratio is 239.97 and the forward PE ratio is 13.12. Gilead Sciences's PEG ratio is -2.62.

    PE Ratio

    n/a
    		 239.97

    Forward PE

    n/a
    		 13.12

    PS Ratio

    n/a
    		 4.01

    Forward PS

    n/a
    		 4

    PB Ratio

    n/a
    		 5.96

    P/FCF Ratio

    n/a
    		 11.18

    PEG Ratio

    n/a
    		 -2.62
    Financial Ratio History

    Enterprise Valuation

    Gilead Sciences has an Enterprise Value (EV) of 131.91B.

    EV / Sales

    n/a
    		 4.59

    EV / EBITDA

    n/a
    		 29.75

    EV / EBIT

    n/a
    		 12.18

    EV / FCF

    n/a
    		 12.8

    Financial Position

    The company has a current ratio of 1.6, with a Debt / Equity ratio of 1.38.

    Current Ratio

    n/a
    		 1.6

    Quick Ratio

    n/a
    		 1.45

    Debt / Equity

    n/a
    		 1.38

    Debt / EBITDA

    n/a
    		 6.02

    Debt / FCF

    n/a
    		 2.59

    Interest Coverage

    n/a
    		 1.7

    Financial Efficiency

    Return on Equity is 2.48% and Return on Invested Capital is 2.36%.

    Return on Equity

    n/a
    		 2.48%

    Return on Assets

    n/a
    		 0.81%

    Return on Invested Capital

    n/a
    		 2.36%

    Revenue Per Employee

    n/a
    		 $1,633,750

    Profits Per Employee

    n/a
    		 $27,272.73

    Employee Count

    n/a
    		 17,600

    Asset Turnover

    n/a
    		 0.49

    Inventory Turnover

    n/a
    		 3.66

    Taxes

    Income Tax

    n/a
    		 211M

    Effective Tax Rate

    n/a
    		 30.58%

    Stock Price Statistics

    The stock price has increased by 69.01% in the last 52 weeks. The beta is 0.31, so Gilead Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.31

    52-Week Price Change

    n/a
    		 69.01%

    50-Day Moving Average

    n/a
    		 105.83

    200-Day Moving Average

    n/a
    		 97.12

    Relative Strength Index (RSI)

    n/a
    		 53.86

    Average Volume (20 Days)

    n/a
    		 9,333,119

    Income Statement

    In the last 12 months, Gilead Sciences had revenue of 28.75B and earned 480M in profits. Earnings per share was 0.38.

    Revenue

    n/a
    		 28.75B

    Gross Profit

    n/a
    		 22.5B

    Operating Income

    n/a
    		 1.66B

    Net Income

    n/a
    		 480M

    EBITDA

    n/a
    		 4.43B

    EBIT

    n/a
    		 1.67B

    Earnings Per Share (EPS)

    n/a
    		 0.38
    Full Income Statement

    Balance Sheet

    The company has 9.99B in cash and 26.71B in debt, giving a net cash position of -16.72B.

    Cash & Cash Equivalents

    n/a
    		 9.99B

    Total Debt

    n/a
    		 26.71B

    Net Cash

    n/a
    		 -16.72B

    Retained Earnings

    n/a
    		 11.5B

    Total Assets

    n/a
    		 56.43B

    Working Capital

    n/a
    		 4.56B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 10.83B and capital expenditures -523M, giving a free cash flow of 10.3B.

    Operating Cash Flow

    n/a
    		 10.83B

    Capital Expenditures

    n/a
    		 -523M

    Free Cash Flow

    n/a
    		 10.3B

    FCF Per Share

    n/a
    		 8.26
    Full Cash Flow Statement

    Margins

    Gross margin is 78.26%, with operating and profit margins of 5.78% and 1.67%.

    Gross Margin

    n/a
    		 78.26%

    Operating Margin

    n/a
    		 5.78%

    Pretax Margin

    n/a
    		 2.4%

    Profit Margin

    n/a
    		 1.67%

    EBITDA Margin

    n/a
    		 15.42%

    EBIT Margin

    n/a
    		 5.78%

    FCF Margin

    n/a
    		 35.84%

    Dividends & Yields

    GILD pays an annual dividend of $3.89, which amounts to a dividend yield of 2.78%.

    Dividend Per Share

    n/a
    		 $3.89

    Dividend Yield

    n/a
    		 2.78%

    Dividend Growth (YoY)

    n/a
    		 2.6%

    Payout Ratio

    n/a
    		 50.26%

    Earnings Yield

    n/a
    		 0.42%

    FCF Yield

    n/a
    		 8.95%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GILD.

    Price Target

    n/a
    		 $110

    Price Target Difference

    n/a
    		 0%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 23
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $9.5

    Lynch Upside

    n/a
    		 -91.36%

    Graham Number

    n/a
    		 11.59

    Graham Upside

    n/a
    		 -89.46%

    Stock Splits

    The last stock split was on Jan 28, 2013. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jan 28, 2013

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 3.5

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist